MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 167 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2014. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $246,000 | +1.2% | 13,991 | 0.0% | 0.21% | -4.6% |
Q4 2018 | $243,000 | +22.1% | 13,991 | +24.5% | 0.22% | +98.2% |
Q3 2014 | $199,000 | -17.4% | 11,234 | -3.8% | 0.11% | -11.3% |
Q2 2014 | $241,000 | -2.4% | 11,678 | +3.0% | 0.12% | +0.8% |
Q1 2014 | $247,000 | -17.9% | 11,338 | 0.0% | 0.12% | -24.1% |
Q4 2013 | $301,000 | – | 11,338 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |